---
$id: https://graph.org.ai/products/commodity/51171814
$type: Product
source: UNSPSC
code: "51171814"
title: "Dolasetron"
class: "51171800"
classTitle: "Antiemetics and antinauseants and antivertigo agents"
family: "51170000"
familyTitle: "Drugs affecting the gastrointestinal system"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Dolasetron

**UNSPSC Code**: 51171814
**Class**: [Antiemetics and antinauseants and antivertigo agents](Antiemetics and antinauseants and antivertigo agents.mdx)
**Family**: [Drugs affecting the gastrointestinal system](../Drugs affecting the gastrointestinal system.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a 5-ht3 receptor antagonist and antiemetic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 82WI2L7Q6E. European Medicines Agency schedules Dolasetron in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06352MIG. Dolasetron generally arises in the molecular formula C19H20N2O3. The term DOLASETRON is an International Non-Proprietary Name or INN. DOLASETRON is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule dolasetron under HS 29339990 and SITC 51577. As of Q4 2014, DOLASETRON remains the US FDA Preferred Term for this commodity. Dolasetron bears US NLM identifiers UMLS ID C0209210 and NCI Concept Code C61735. SMILES: O(C1CC2N3C(CC(C2)C(=O)C3)C1)C(=O)C1C2C([NH]C1)CCCC2.

